MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1152/ajplung.00372.2024

Медицинская библиотека · American journal of physiology. Lung cellular and molecular physiology · 2025

The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials.

Schaich Christopher L, Chappell Mark C, Shotwell Matthew S, Joly Meghan M, Gibbs Kevin W, Barksdale Aaron, Douglas Ivor S, Chen Peter, Levitt Joseph E, Puskarich Michael A, Rice Todd W, Harkins Michelle S, Hudock Kristin M, Lanspa Michael J, Ginde Adit A, Self Wesley H, Collins Sean P, Files D Clark, ACTIV-4 Host Tissue Investigators

СтатьяПеревод в очереди

Аннотация

SARS-CoV-2 targets angiotensin-converting enzyme-2 (ACE2), a key peptidase of the renin-angiotensin system (RAS), which regulates the balance of the vasoconstrictor/inflammatory peptide Ang II and the vasodilator/anti-inflammatory peptide Ang-(1-7). Few studies have quantified the circulating elements of the RAS longitudinally in SARS-CoV-2 infection and their association with COVID-19 outcomes. Thus, we evaluated the association of circulating RAS enzymes and peptides with mortality among patients with COVID-19. Blood samples were collected from 111 patients with COVID-19 and new-onset hypoxemia during the delta and omicron waves at 19 hospitals in the United States. Circulating RAS components were quantified via radioimmunoassay or ELISA at 0 (baseline), 1, 3, and 5 days after randomization. We used multivariable Cox regression to estimate the association of baseline and longitudinal RAS concentrations with 90-day mortality. Participants were aged 18-90 (means [SD]: 55 [14]) yr and 62% were male. There were 22 (20%) deaths over 90 days of follow-up. ACE2 levels above the sample median (≥4.9 pM; adjusted HR [95% CI]: 0.10 [0.02, 0.43]) and ACE2/ACE ratio (≥6.0 × 10-3; adjusted HR: 0.08 [0.02, 0.39]) were associated with significantly lower mortality. Similarly, when analyzed as continuous, log2-normalized, time-varying predictors from day 0 to day 5, twofold increments of ACE2 and ACE2/ACE ratio over this period were associated with lower mortality (adjusted HR: 0.79 [0.65, 0.97] and 0.78 [0.63, 0.97], respectively). Circulating Ang II, Ang-(1-7), and ACE levels were not associated with mortality. These results suggest higher circulating ACE2 protein in hospitalized patients with COVID-19 is associated with reduced mortality.NEW & NOTEWORTHY We measured circulating components of the renin-angiotensin system (RAS) longitudinally over 5 days among patients hospitalized with COVID-19 and new-onset hypoxemia. We found that higher serum angiotensin-converting enzyme (ACE)-2 protein and ACE2/ACE ratio, both at baseline and when analyzed as time-varying, repeated measures, were associated with lower 90-day mortality. Results suggest a role for circulating ACE2 as a biomarker of adverse outcomes and could inform treatment strategies targeting the RAS in severe COVID-19 illness.

Для цитирования: Schaich Christopher L, Chappell Mark C, Shotwell Matthew S, Joly Meghan M, Gibbs Kevin W, Barksdale Aaron, Douglas Ivor S, Chen Peter, Levitt Joseph E, Puskarich Michael A, Rice Todd W, Harkins Michelle S, Hudock Kristin M, Lanspa Michael J, Ginde Adit A, Self Wesley H, Collins Sean P, Files D Clark, ACTIV-4 Host Tissue Investigators. The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials.. American journal of physiology. Lung cellular and molecular physiology. 2025. DOI: 10.1152/ajplung.00372.2024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.